Detalles MARC
| 000 -CABECERA |
|---|
| campo de control de longitud fija |
10686nam a22004213i 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| campo de control |
232336 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| campo de control |
ES-VaUE |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
|---|
| campo de control |
20220611162920.0 |
| 006 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA--CARACTERÍSTICAS DEL MATERIAL ADICIONAL |
|---|
| campo de control de longitud fija |
m o d | |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
cr cnu|||||||| |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
211214s2021 xx o ||||0 eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
978-3-030-84546-9 |
| 024 ## - IDENTIFICADOR DE OTROS ESTÁNDARES |
|---|
| Fuente del número o código |
doi |
| Número estándar o código |
10.1007/978-3-030-84546-9 |
| 040 ## - FUENTE DE LA CATALOGACIÓN |
|---|
| Centro catalogador/agencia de origen |
MiAaPQ |
| Lengua de catalogación |
eng |
| Normas de descripción |
rda |
| -- |
pn |
| Centro/agencia transcriptor |
MiAaPQ |
| Centro/agencia modificador |
MiAaPQ |
| 050 ## - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de clasificación |
RC280 |
| Número de documento/Ítem |
.M63 2022 EB |
| 245 10 - MENCIÓN DE TÍTULO |
|---|
| Título |
Modern Breast Cancer Imaging |
| Mención de responsabilidad, etc. |
edited by Su Jin Kim Hsieh, Elizabeth Anne Morris |
| 250 ## - MENCIÓN DE EDICIÓN |
|---|
| Mención de edición |
1st ed. |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Producción, publicación, distribución, fabricación y copyright |
Cham |
| Nombre del de productor, editor, distribuidor, fabricante |
Springer International Publishing AG |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2022 |
| 264 #4 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Fecha de producción, publicación, distribución, fabricación o copyright |
2022 |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extensión |
1 online resource (XV, 471 pages) |
| Otras características físicas |
147 b/w illustrations, 182 illustrations in colour |
| 336 ## - TIPO DE CONTENIDO |
|---|
| Término de tipo de contenido |
text |
| Código de tipo de contenido |
txt [ |
| Fuente |
rdacontent] |
| 337 ## - TIPO DE MEDIO |
|---|
| Nombre/término del tipo de medio |
computer |
| Código del tipo de medio |
c [ |
| Fuente |
rdamedia] |
| 338 ## - TIPO DE SOPORTE |
|---|
| Nombre/término del tipo de soporte |
online resource |
| Código del tipo de soporte |
cr [ |
| Fuente |
rdacarrier] |
| 505 0# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Intro -- Foreword -- Preface -- Contents -- Contributors -- Part I: Updates in Clinical and Pathological Aspects for Breast Cancer -- Chapter 1: Molecular Basis ofBreast Cancer -- 1.1 Introduction -- 1.2 BC (Basal Carcinomas) andTNC (Triple Negative Carcinomas) -- 1.3 Luminal Carcinomas (LC) -- 1.4 HER2-Enriched Carcinomas -- References -- Chapter 2: Risk Factors forBreast Cancer -- 2.1 Introduction -- 2.2 Gender andAge -- 2.3 Reproductive Factors -- 2.4 Gestation andLactation -- 2.5 Contraception andHormone Replacement Therapy -- 2.6 Obesity -- 2.7 Alcohol andSmoking -- 2.8 Thoracic Radiation Therapy -- 2.9 Precursor Injuries -- 2.10 Hereditary Syndromes andBreast Cancer -- 2.11 Genes andAssociated Syndromes -- 2.11.1 Genes Associated withHigh Penetrance -- 2.11.2 Genes Associated withModerate Penetrance -- 2.12 Quantification ofMutation Risk -- 2.13 Genetic Testing forHigh-Risk Patients -- References -- Chapter 3: Genomic Tests -- 3.1 Introduction -- 3.2 Gene Expression Assays -- 3.2.1 Oncotype DX -- 3.2.2 MammaPrint -- 3.2.3 Other Assays -- 3.3 Concordance ofExpression Assays -- 3.4 Conclusion -- References -- Chapter 4: Updates inSurgical Approaches forBreast andAxilla -- 4.1 Introduction -- 4.2 Axillary Management inClinically Node-Negative Patients withInvasive Breast Cancer -- 4.3 Axillary Management inMicrometastases (N1m1) or Isolated Tumor Cells N (+1) Patients withInvasive Breast Cancer -- 4.4 Axillary Management inClinically Node-Negative Patients andMacrometastases inthePathology withInvasive Breast Cancer -- 4.5 Axillary Management inClinically Node-Positive Patients andNeoadjuvant Chemotherapy (NAC) Treatment -- References -- Chapter 5: Pathological Aspects forDiagnosis -- 5.1 Pre-analytical Procedures -- 5.2 Radiological-Pathological Correlation -- 5.3 Fibroepithelial Lesions -- 5.4 Papillary Neoplasms |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
5.5 Benign High-Risk Lesions andPrecursors, Including Classic Lobular Intraepithelial Neoplasia -- 5.6 Atypical Ductal Hyperplasia andLow-Grade Carcinoma InSitu -- 5.7 Intermediate andHigh-Grade Ductal Carcinoma InSitu -- 5.8 Pleomorphic Lobular Carcinoma InSitu (PLCIS) -- 5.9 Biomarkers inDuctal Carcinoma InSitu -- 5.10 Invasive Carcinoma ofNo Special Type -- 5.11 Macroscopic Evaluation oftheBreast Specimen, Including Those withNeoadjuvant Treatment -- 5.12 Special Subtypes -- 5.13 Special Methods -- 5.13.1 Immunohistochemistry -- 5.13.2 In Situ Hybridization -- 5.14 Next-Generation Sequencing (NGS) -- References -- Part II: Update in Imaging Method -- Chapter 6: Radiation Based Imaging: Digital Mammography, Tomosynthesis -- 6.1 Introduction -- 6.2 Technique -- 6.3 Indications -- 6.4 Interpretation -- 6.4.1 Breast Composition -- 6.4.2 Masses -- 6.4.3 Calcifications -- 6.4.4 Architectural Distortion -- 6.4.5 Asymmetries -- 6.4.6 Intramammary Lymph Node -- 6.4.7 Skin Lesions -- 6.4.8 Single Dilated Duct -- 6.4.9 Associated Findings -- 6.4.10 Location ofLesions -- 6.4.11 ACR-BI-RADS Final Assessment -- 6.4.12 Recommendation -- 6.5 Conclusions -- References -- Chapter 7: Sonographic Based Imaging: Ultrasound, Color Doppler, Elastography, andAutomated Breast Imaging -- 7.1 Introduction -- 7.2 Scanning Technique -- 7.2.1 The Ideal Image -- 7.2.2 Anatomy -- 7.2.3 Harmonic -- 7.2.4 Compound Imaging -- 7.3 Doppler Evaluation -- 7.4 Elastography -- 7.4.1 Strain Elastography -- 7.4.2 Shear Wave Elastography -- 7.5 Automated Breast Ultrasound -- 7.6 Correlation withOther Imaging Methods -- 7.7 Exam Documentation -- 7.8 BI-RADS Lexicon -- 7.9 Report andAssessment -- 7.9.1 BI-RADS Categories -- References -- Chapter 8: Magnetic Resonance Imaging: Regular Protocols andFast Protocols -- 8.1 Introduction -- 8.2 Standard Examination |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
8.3 T2-Weighted Images -- 8.4 T1-Weighted Images -- 8.5 Subtraction, Enhancement Curve, and3D MIP -- 8.6 Diffusion-Weighted Images -- 8.7 Breast Implants -- 8.8 Abbreviated Protocol -- 8.9 Ultrafast Breast MRI -- 8.10 Conclusion -- References -- Chapter 9: Nuclear Medicine Based Methods: PET FDG andOther Tracers -- 9.1 Introduction -- 9.1.1 Basic Aspects of18F-FDG-PET -- 9.2 18F-FDG-PET/CT Indications inBreast Cancer -- 9.2.1 Primary Breast Tumor Detection andStaging (T) -- 9.2.2 Nodal Staging (N) -- 9.2.3 Metastatic Staging (M) -- 9.2.4 Recurrence -- 9.2.5 Response Assessment toNeoadjuvant Chemotherapy (NAC) -- 9.2.6 Response Assessment inMetastatic Disease -- 9.3 Prognostic Value -- 9.4 Other PET Technologies andTracers -- 9.4.1 PET/MR andPositron Emission Mammography (PEM) -- 9.4.2 Non-FDG Tracers forBreast Cancer -- 9.5 Conclusion -- References -- Chapter 10: Image-Guided Percutaneous Biopsies -- 10.1 Historical Perspective -- 10.2 Understanding Imaging-Guidance andNeedle Selection: Practical Considerations -- 10.3 Pre-biopsy Assessment -- 10.4 Patient Preparation, Biopsy Risks, andGeneral Post-biopsy Information -- 10.5 Considerations Regarding Clip Placement -- 10.6 Clip Placement Complications -- 10.7 Ultrasound-Guided Biopsy -- 10.8 Fine-Needle Aspiration (FNA) -- 10.8.1 Axillary Assessment -- 10.8.2 Cysts -- 10.8.3 Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) -- 10.8.4 Challenging Lesion Location -- 10.8.5 Diagnostic Accuracy andAvailability -- 10.9 Technique -- 10.10 Complications andPost-care -- 10.10.1 Ultrasound-Guided Core Needle Biopsy andVacuum-Assisted Biopsy -- 10.10.2 Sampling Considerations -- 10.11 Quantity andQuality oftheSample -- 10.12 Adequate Targeting -- 10.13 Choosing Between VAB andCNB -- 10.13.1 Therapeutic VAB -- 10.13.2 VAB andCNB Technique -- 10.14 Mammography-Guided Biopsy |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
10.15 Stereotactic Biopsy -- 10.16 Upright Add-On andProne Table Biopsy Systems -- 10.17 The Procedure -- 10.18 Digital Breast Tomosynthesis-Guided Biopsy -- 10.19 DBT Versus Stereotactic Guided Biopsy -- 10.20 The Procedure -- 10.21 Technical Challenges andPossible Solutions (DBT andStereotactic Biopsy) -- 10.21.1 Subtle Findings -- 10.21.2 Far Posterior Lesions -- 10.21.3 Thin Breasts -- 10.22 Superficial Lesions -- 10.23 MRI-Guided Biopsy -- 10.23.1 Second-Look Ultrasound andSecond-Look Mammography -- 10.23.2 Second-Look Mammography -- 10.23.3 The Procedure -- 10.23.4 Complications andPost-biopsy Care -- 10.24 Imaging-Pathology Correlation -- 10.25 Discordant Biopsy -- 10.25.1 Concordant Malignancy -- 10.25.1.1 Discordant Malignancy -- 10.25.2 Concordant Benign -- 10.25.3 Discordant Benign -- 10.25.4 High-Risk andBorderline Lesions -- References -- Chapter 11: Breast Imaging Preoperative Localization Procedure -- 11.1 Introduction -- 11.2 Indications ofPreoperative Localization -- 11.3 Pre-procedure Review ofPreoperative Localization -- 11.4 Wire Localization -- 11.4.1 MG-Guided andStereotactic-Guided Wire Localization -- 11.4.1.1 Technique Using aPerforated or Marked Compression Plate -- 11.4.1.2 Technique Using aStereotactic Table -- 11.4.2 US-Guided Wire Localization -- 11.4.3 MRI-Guided Wire Localization -- 11.4.4 Wire Variations -- 11.5 Nonwire Localization Methods -- 11.5.1 Carbon Marking -- 11.5.2 Radio-Guided Occult Lesion Localization (ROLL) -- 11.5.2.1 Sentinel Node andOccult Lesion Localization (SNOLL) -- 11.5.3 Current Lesion Localization Techniques -- 11.5.3.1 Radioactive Nonwire Localization Device -- Radioactive Seed Localization -- 11.5.3.2 Non-radioactive Wireless Localization Devices -- Radar Reflector Localization -- Magnetic Seed Localization -- Radiofrequency Identification Tag (RFID) Localization |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
11.6 Post-procedure Complications -- 11.7 Post-procedure Assessment -- References -- Part III: Different Clinical Scenario: Clinical Management and Role of Imaging Modalities -- Chapter 12: Screening -- 12.1 Introduction -- 12.2 Screen-Film Mammography -- 12.3 Digital Mammography -- 12.4 Tomosynthesis -- 12.5 Magnetic Resonance Imaging (MRI) -- 12.6 Ultrasound -- 12.7 Molecular Breast Imaging -- 12.8 Clinical Breast Examination -- 12.9 Breast Self-Examination -- 12.10 Thermography -- 12.11 Elastography -- 12.12 Screening inSpecial Populations -- 12.12.1 Increased Breast Density -- 12.12.2 High-Risk ofBreast Cancer -- 12.12.3 Elderly Women -- References -- Chapter 13: Diagnostic -- 13.1 Diagnostic Management ofClinical Situations -- 13.1.1 Palpable Changes oftheBreast -- 13.1.1.1 Breast Lump -- 13.1.1.2 Paget Disease -- 13.1.1.3 Occult Breast Cancer andAxillary Lymphadenopathy -- 13.1.2 Non-palpable Breast Changes -- 13.1.2.1 Image Screening Findings -- 13.1.2.2 Nipple Discharge -- 13.1.3 Breast Biopsy inClinical Scenario -- 13.1.3.1 US andMammography-Guided Biopsy (Fine-Needle Aspiration (FNA)/Core-Needle Biopsy (CNB)/Vacuum Aspiration Biopsy (VAB)) -- 13.1.3.2 MRI- andDBT-Guided Biopsy -- References -- Chapter 14: Preoperative (Breast) -- 14.1 Preoperative Tests fortheBreast -- 14.1.1 Imaging Methods -- 14.1.1.1 Mammography -- 14.1.1.2 Ultrasound -- 14.1.1.3 Tomosynthesis -- 14.1.1.4 Breast Magnetic Resonance Imaging -- 14.1.1.5 Positron Emission Tomography-Computed Tomography (PET-CT) -- 14.2 Preoperative Tests fortheAxilla -- 14.2.1 Indications -- 14.2.2 Methods -- 14.2.2.1 Ultrasound -- 14.2.2.2 Mammography -- 14.2.2.3 Magnetic Resonance Imaging -- 14.2.2.4 PET-CT -- 14.3 Case Examples -- 14.3.1 Case 1 -- 14.3.2 Case 2 -- 14.3.3 Case 3 -- 14.3.4 Case 4 -- 14.3.5 Case 5 -- References |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Chapter 15: Systemic Staging (Total Body- When, How) |
| 650 #7 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| Fuente del encabezamiento o término |
embne |
| 9 (RLIN) |
37361 |
| Término de materia o nombre geográfico como elemento de entrada |
Enfermedades |
| Subdivisión general |
Complicaciones |
| 655 #4 - TÉRMINO DE INDIZACIÓN--GÉNERO/FORMA |
|---|
| Datos o término principal de género/forma |
Electronic books |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Morris, Elizabeth Anne |
| 700 ## - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Hsieh, Su Jin Kim |
| 9 (RLIN) |
517866 |
| 776 ## - ENTRADA/ENLACE A UN FORMATO FÍSICO ADICIONAL |
|---|
| Número Internacional Estándar del Libro |
3-030-84545-1 |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Identificador Uniforme del Recurso |
https://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-84546-9 |
| Nota pública |
Acceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) |
|---|
| Fuente del sistema de clasificación o colocación |
Library of Congress Classification |
| Tipo de ítem Koha |
LIBRO-E NO PRÉSTAMO |
| 998 ## - DATOS ESTADÍSTICOS |
|---|
| Tipo de materia |
E-book |